Epigenetic and Cortisol Level Reflections of Maternal Stress During Pregnancy

NCT07764380 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2026-08-13

No results posted yet for this study

Summary

The aim of this study is to evaluate the effects of stress management and epigenetic awareness training provided in prenatal classes on maternal stress levels, cortisol levels, and epigenetic awareness.

The main questions it aims to answer are:

1. Do stress management and epigenetic awareness training provided in prenatal classes affect pregnant women's cortisol levels?
2. Does the training affect pregnant women's knowledge and awareness of epigenetic effects?

Conditions

  • Pregnancy

Interventions

BEHAVIORAL

Maternal Epigenetics Training Module

The Maternal Epigenetics Education Module is a structured educational intervention designed to reduce stress levels in expectant mothers during pregnancy, raise their awareness of the effects of stress on both the mother and the fetus, and promote healthy lifestyle behaviors within the framework of epigenetic mechanisms. The module addresses the relationship between stress, epigenetics, and fetal health during pregnancy from a scientific perspective and aims to equip expectant mothers with basic skills for managing stress.

Sponsors & Collaborators

  • Kahramanmaras Sutcu Imam University

    lead OTHER

Principal Investigators

  • ESRA KARATAŞ OKYAY, PhD · Kahramanmaras Sutcu Imam University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-15
Primary Completion
2026-09-15
Completion
2026-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07764380 on ClinicalTrials.gov